Article Details
Retrieved on: 2022-01-21 19:31:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Reuters) - GlaxoSmithKline and U.S. partner Vir Biotechnology will boost production of their antibody-based COVID-19 treatment by adding a second ...
Article found on: kdal610.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here